Shield Therapeutics

(STX)
Sector: Pharmaceuticals & Biotechnology
2.82p
-0.03p -1.05
Last updated: 11:50:29

Director dealings

Trade date Director Volume / Price Trade value Trade type
21/11/2023 Hans-Peter Hasler 2,000,000 @ 6.10p £122,000.00 Buy
23/12/2022 Greg Madison 466,395 @ 6.80p £31,714.86 Sell
19/03/2021 Christian Schweiger 0 @ 0.00 0.00 Notification of Holding
17/03/2021 Peter Llewellyn-Davies 1,176 @ 30.00p £352.80 Placing
17/03/2021 Christian Schweiger 250,000 @ 30.00p £75,000.00 Placing
05/03/2021 Hans-Peter Hasler 200,000 @ 37.50p £75,000.00 Buy
03/03/2021 Hans-Peter Hasler 200,000 @ 37.38p £74,760.00 Buy
20/01/2021 Hans-Peter Hasler 100,000 @ 59.00p £59,000.00 Buy
19/01/2021 Tim Watts 100,000 @ 60.25p £60,250.00 Buy
18/12/2020 Tim Watts 100,000 @ 1.50p £1,500.00 Exercise of Option
11/12/2020 Tim Watts 100,000 @ 69.75p £69,750.00 Buy
13/08/2019 James M Karis 75,000 @ 178.00p £133,500.00 Buy
25/04/2019 Mark Sampson 22,042 @ 90.70p £19,992.09 Buy
25/03/2019 Mark Sampson 22,875 @ 87.40p £19,992.75 Buy
16/04/2019 Carl Sterritt 123,690 @ 1.50p £1,855.35 Exercise of Option
16/04/2019 James M Karis 4,000 @ 81.00p £3,240.00 Buy
15/04/2019 James M Karis 46,000 @ 81.50p £37,490.00 Buy
21/09/2018 Carl Sterritt 88,235 @ 34.00p £29,999.90 Buy
04/10/2017 Carl Sterritt 8,814 @ 100.00p £8,814.00 Exercise of Option

Director shareholdings

Name Holding Percent
Hans-Peter Hasler 5,500,000 0.00%
Greg Madison 533,605 0.00%
Christian Schweiger 0 0.00%
Peter Llewellyn-Davies 0 0.00%

Major shareholders

Institution name Holding Percent
AOP Orphan Pharmaceuticals AG 158,070,394 26.99%
Nutrition-Wellness Venture SA 56,008,541 7.85%
Jupiter Fund Management plc 34,127,697 4.78%
Premier Miton Group PLC 30,000,000 5.41%
MaRu AG 12,532,918 0.00%
JPMorgan Asset Management Holdings Inc. 6,238,846 5.37%
Universities Superannuation Scheme Ltd 5,067,985 2.35%